What question did this study set out to answer?

This research aims to assess the reliability and efficiency of the i-TRACK10 CLIA analyzer for anti-TNF drug monitoring compared to ELISA.

April 16, 2026Clinical Laboratory0 citations

Evaluating Random-Access CLIA for Anti-TNF Drug Monitoring: a Comparison with Traditional ELISA

OAOlga AshorovTel Aviv University YHYair HutaBar-Ilan University RGRachel Gingold-Belfer

Key Points

This research aims to assess the reliability and efficiency of the i-TRACK10 CLIA analyzer for anti-TNF drug monitoring compared to ELISA.
Evaluation of i-TRACK10 analyzer using anti-TNF agents.
Comparison with traditional ELISA kits.
Assessment of accuracy and efficiency in drug monitoring.
The i-TRACK10 analyzer demonstrated higher accuracy compared to conventional ELISA.
Enhanced automation reduced processing time significantly.
Integration into clinical workflows is supported by improved performance characteristics.

Abstract

The i-TRACK10 analyzer provides a reliable, accurate, and efficient alternative to traditional ELISA kits for therapeutic drug monitoring of anti-TNF agents. Its enhanced automation and performance characteristics support its integration into routine clinical laboratory workflows.

Ask AI

Helpful

Bookmark

View Full Paper